Caribou Biosciences, Inc. (CRBU) Tops Q1 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St rises as oil falls heading into US midterm elections
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts CRBU Hot Sheet
Join SI Premium – FREE
Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q1 EPS of ($0.26), $0.07 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $2.39 million versus the consensus estimate of $2.65 million.
For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Estee Lauder (EL) PT Raised to $129 at Goldman Sachs
- AT&T and AST SpaceMobile complete ground-to-satellite network handoff
- Marvell (MRVL) PT Lowered to $275 at B.Riley
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
